A pharmacokinetic -pharmacodynamic model for the mobilization of CD34⁺ hematopoietic progenitor cells by AMD3100LACK, N. A; GREEN, B; DALE, D. C et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 5, pp 427-436, issn 0009-9236, 10 p.Article

Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patientsFRUEHAUF, S; EHNINGER, G; HÜBEL, K et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 269-275, issn 0268-3369, 7 p.Article

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilizationDUGAN, M. J; MAZIARZ, R. T; BENSINGER, W. I et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 1, pp 39-47, issn 0268-3369, 9 p.Article

AMD3100 plus G-CSF can successfully mobilize CD34 + cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment : compassionate use dataCALANDRA, G; MCCARTY, J; MCGUIRK, J et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 4, pp 331-338, issn 0268-3369, 8 p.Article